论文部分内容阅读
莫斯科市立包特金临床医院内科,应用调剂学硕士特拉斯科夫与化验-化学家斯克雷普尼克二人共同提议的制剂来治疗支气管气喘患者已经有二年多了,并且已获得了成绩。服用过特拉斯科夫合剂的大部分患者,在用药的一星期左右,气喘便停止发作,喘息状态和肺部曪音均行消失(在有显明的肺硬化时,仍然有干性曪音),呼吸也恢复正常。肺活量增加到3,000—4,000毫升,睡眠和食欲均获得改善;某些患者,
The treatment of patients with bronchial asthma for the preparation of a master’s program administered by the Master of Medicine in the Moscow State’s Bautkin Clinical Hospital, the Master of Medicine in Transfer Medicine, and the laboratory-chemist Scripnik, has been completed for more than two years and has achieved results. . Most patients who took Traskoff mixture stopped breathing for a week or so after the medication, and both wheezing and lung sounds disappeared. There was still a dry voice in the presence of obvious lung sclerosis. ), breathing also returned to normal. Increased lung capacity to 3,000-4,000 ml, improved sleep and appetite; in some patients,